Lipid Association of India (LAI) is a team of eminent doctors in the field of Cardiovascular Medicine, Internal Medicine, Pharmacology and young doctors who are interested in the field of lipidology.
In India the incidence of dyslipidemia is reported to be between 10-13% in various studies, thus reflecting the magnitude of this health problem when viewed in context of a population of 1.27 billion. Studies have also shown that prevalence of atherogenic small, dense LDL, hypertriglyceridemia and abnormally low HDL is significantly higher in Asian Indians as compared with white Caucasians in USA. Therefore, the guidelines on hyperlipidemia management by the American College of Cardiology and the American Heart Association may not be applicable to Indian population.
Our objective is to focus on research activities related to prevalence of dyslipidemia in Indian population and to formulate guidelines for dyslipidemia management for Indians. We will also be working towards creating awareness among general public regarding the adverse effects of dyslipidemia in order to achieve our aim of “A Healthy Heart for Better Tomorrow”.
LAICON 2020: International October 2020 at New Delhi
Date to be announce
5th Lipidology Certification Course (LCC)
5th Lipidology Certification Course (LCC) on October 2020 at New Delhi
Familial Hypercholesterolemia Registry
Every year LAI organizes some sports activity to create awareness in public about cardiovascular diseases. World Health Organizations estimates that by 2020 more than 50% of cardiac patients worldwide will be Indians.
Congratulations to LAI for being accepted as member of IAS and also bring out the recommendations.I went through them and found them quite elaborate,and practical for Indian context and whole heartedly support them.I wish these recommendations may be of immense benefits for physicians. Hence, they need to be popularised, which needs an early publication.Wish LAI and its ventures a great success.